Improving analysis of lipids and sugars for clinical use
Integrating Accelerated Droplet Chemistry with LC-MS for High Throughput Quantitative Analysis
This study is working on a new way to measure fats and sugars in the body more accurately, which could help doctors diagnose and treat health issues better, especially when only tiny samples are available.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10997415 on NIH RePORTER |
What this research studies
This research focuses on enhancing the analysis of lipids and saccharides, which are important for understanding various biological processes. The team is developing a novel mass spectrometry technique that uses accelerated droplet chemistry to improve the sensitivity and accuracy of measurements. By addressing challenges in isolating specific compounds, this method aims to provide reliable quantitative data from very small sample volumes, which is crucial for clinical applications. Patients may benefit from better diagnostic tools and treatments based on improved understanding of these biomolecules.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that affect lipid and sugar metabolism, such as diabetes or metabolic syndrome.
Not a fit: Patients with conditions unrelated to lipid or sugar metabolism may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostic tools and treatments for conditions related to lipid and sugar metabolism.
How similar studies have performed: Other research has shown promise in using advanced mass spectrometry techniques for biomolecular analysis, indicating potential success for this novel approach.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Badu-Tawiah, Abraham — Ohio State University
- Study coordinator: Badu-Tawiah, Abraham
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.